FIZE News

FIZE Medical, a pioneer in transforming the standard of care for critically ill patients including pediatrics is proud to announce it has been awarded a single supplier status by Clalit Health Services, Israel’s largest HMO

FIZE Medical's patented device, FIZE kUO, offers continuous digital monitoring of kidney urine output with unprecedented accuracy in patients of all ages, including pediatrics. This cutting-edge technology empowers healthcare professionals to detect kidney function deterioration early on, enabling prompt intervention and customized treatment plans.

I joined FIZE Medical in August 2022 as an implementation specialist in FIZE’s commercial team. In my spare time, I love to mountain hike, and have been to some very special places including Mount Blan

ASE Direct, Inc. Receives Innovative Technology Contract from Vizient for FIZE kUO

FIZE Medical has achieved a significant milestone in revolutionizing critical patient care with the FIZE kUO device. Our flagship product, in partnership with ASE Direct, has been granted an Innovative

Total financing for market launch and penetration surpasses $9 million mark Breakthrough “FIZE kUO™” device for monitoring real-time kidney urine output to enter hospitals in 1Q22 MODI’IN, Israel

MIAMI, April 6, 2021 /PRNewswire/ – FIZE Medical, Inc. (“FIZE”)(www.fizemedical.com) recently closed a Series A financing led by Rapha Capital Management, LLC

MIAMI, May 4, 2020 /PRNewswire/ — Rapha Capital Management, LLC (http://www.raphacap.com), an investment management firm located in Miami, Florida,